These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16234535)

  • 1. Is TGFBR1*6A really associated with increased risk of cancer?
    Zhang HT; Zhao J; Zheng SY; Chen XF
    J Clin Oncol; 2005 Oct; 23(30):7743-4; author reply 7744-6. PubMed ID: 16234535
    [No Abstract]   [Full Text] [Related]  

  • 2. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.
    Pasche B; Kaklamani V; Hou N; Young T; Rademaker A; Peterlongo P; Ellis N; Offit K; Caldes T; Reiss M; Zheng T
    J Clin Oncol; 2004 Feb; 22(4):756-8. PubMed ID: 14966109
    [No Abstract]   [Full Text] [Related]  

  • 3. No major association between TGFBR1*6A and prostate cancer.
    Kaklamani V; Baddi L; Rosman D; Liu J; Ellis N; Oddoux C; Ostrer H; Chen Y; Ahsan H; Offit K; Pasche B
    BMC Genet; 2004 Sep; 5():28. PubMed ID: 15385056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TGF-beta in cancer and the potential for therapy and prevention.
    Kaklamani VG; Pasche B
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):649-61. PubMed ID: 15270668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies.
    Zhang HT
    Lung Cancer; 2005 Sep; 49(3):419-20. PubMed ID: 15955593
    [No Abstract]   [Full Text] [Related]  

  • 7. TGFBR1*6A is not associated with prostate cancer in men of European ancestry.
    Suarez BK; Pal P; Jin CH; Kaushal R; Sun G; Jin L; Pasche B; Deka R; Catalona WJ
    Prostate Cancer Prostatic Dis; 2005; 8(1):50-3. PubMed ID: 15505640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hunting for the real cancer genes.
    Habeck M
    Drug Discov Today; 2003 Nov; 8(21):959-60. PubMed ID: 14643151
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TbetaR-I(6A) polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Correspondence re: B. Pasche et al. Type I TbetaR-I(6A) Is a Candidate Tumor Susceptibility Allele. Cancer Res., 58: 2727-2732, 1998.
    Stefanovska AM; Efremov GD; Dimovski AJ; Jasar D; Zografski G; Josifovski T; Panovski M; Jankova R; Spiroski M
    Cancer Res; 2001 Nov; 61(22):8351-2. PubMed ID: 11719470
    [No Abstract]   [Full Text] [Related]  

  • 11. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
    Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
    Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
    Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
    Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
    J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between TGFBR1*6A and cancer: is there any evidence?
    Lai R
    J Clin Oncol; 2004 Jul; 22(13):2754; author reply 2754-5. PubMed ID: 15226351
    [No Abstract]   [Full Text] [Related]  

  • 15. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?
    Daley D; Morgan W; Lewis S; Willis J; Elston RC; Markowitz SD; Wiesner GL
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):892-4. PubMed ID: 17507611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic stroke in an adolescent with arterial tortuosity syndrome.
    Drera B; Barlati S; Colombi M
    Neurology; 2007 May; 68(19):1637; author reply 1637. PubMed ID: 17485657
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.
    Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF
    Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.
    Wang YQ; Qi XW; Wang F; Jiang J; Guo QN
    PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.